688363 华熙生物
已收盘 06-04 15:00:02
资讯
新帖
简况
每周股票复盘:华熙生物(688363)股东户数减少2.07%,控股东捐赠1%股份
证券之星 · 05-31
每周股票复盘:华熙生物(688363)股东户数减少2.07%,控股东捐赠1%股份
破发股华熙生物跌2.49%创新低 2019年上市募23.69亿
中金财经 · 05-28
破发股华熙生物跌2.49%创新低 2019年上市募23.69亿
股市必读:华熙生物(688363)股东户数3.11万户,较上期减少2.07%
证券之星 · 05-27
股市必读:华熙生物(688363)股东户数3.11万户,较上期减少2.07%
华熙生物(688363)披露2025年年度股东会会议资料,5月25日股价下跌3.13%
证券之星 · 05-25
华熙生物(688363)披露2025年年度股东会会议资料,5月25日股价下跌3.13%
破发股华熙生物跌3.13%创新低 2019年上市募23.69亿
中金财经 · 05-25
破发股华熙生物跌3.13%创新低 2019年上市募23.69亿
每周股票复盘:华熙生物(688363)将参加投资者网上集体接待日活动
证券之星 · 05-17
每周股票复盘:华熙生物(688363)将参加投资者网上集体接待日活动
股市必读:华熙生物一季报 - 第一季度单季净利润同比下降36.55%
证券之星 · 05-06
股市必读:华熙生物一季报 - 第一季度单季净利润同比下降36.55%
每周股票复盘:华熙生物(688363)股东户数增0.69%
证券之星 · 05-02
每周股票复盘:华熙生物(688363)股东户数增0.69%
华熙生物(688363)2026年一季报简析:净利润同比下降36.55%,公司应收账款体量较大
证券之星 · 05-01
华熙生物(688363)2026年一季报简析:净利润同比下降36.55%,公司应收账款体量较大
华熙生物(688363)披露提请股东会授权董事会以简易程序向特定对象发行股票的公告,4月30日股价下跌4.61%
证券之星 · 04-30
华熙生物(688363)披露提请股东会授权董事会以简易程序向特定对象发行股票的公告,4月30日股价下跌4.61%
华熙生物最新公告:第一季度净利润同比下降36.55%
证券之星 · 04-29
华熙生物最新公告:第一季度净利润同比下降36.55%
每周股票复盘:华熙生物(688363)2025年净利增67.59%
证券之星 · 04-26
每周股票复盘:华熙生物(688363)2025年净利增67.59%
股市必读:华熙生物年报 - 第四季度单季净利润同比增长121.13%
证券之星 · 04-24
股市必读:华熙生物年报 - 第四季度单季净利润同比增长121.13%
华熙生物最新公告:2025年净利润2.92亿元同比增长67.59%
证券之星 · 04-22
华熙生物最新公告:2025年净利润2.92亿元同比增长67.59%
国货美妆品牌抢占线下折扣店
21世纪经济报道 · 04-22
国货美妆品牌抢占线下折扣店
破发股华熙生物跌5.81%创新低 2019年上市募23.69亿
中金财经 · 03-23
破发股华熙生物跌5.81%创新低 2019年上市募23.69亿
玻尿酸王座崩塌:华熙生物从1400亿到217亿的生死突围
蓝鲸财经 · 03-16
玻尿酸王座崩塌:华熙生物从1400亿到217亿的生死突围
华熙生物公布国际专利申请:“油性组合物及其用途”
证券之星 · 03-08
华熙生物公布国际专利申请:“油性组合物及其用途”
华熙生物2025年营收42亿:同比降21% 净利2.9亿
雷递网 · 03-02
华熙生物2025年营收42亿:同比降21% 净利2.9亿
每周股票复盘:华熙生物(688363)净利增67.03%
证券之星 · 03-01
每周股票复盘:华熙生物(688363)净利增67.03%
加载更多
公司概况
公司名称:
华熙生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2019-11-06
主营业务:
华熙生物科技股份有限公司的主营业务是研发、生产和销售透明质酸等生物活性物质原料产品及生物医用材料终端产品。公司的主要产品是原料产品、医疗终端产品、皮肤科学创新转化业务。公司坚持科技创新驱动发展,科技创新能力多次获得国家及各级政府认可。公司先后被认定为国家企业技术中心、国家药监局化妆品原料质量控制重点实验室(联合申报)、山东省生物活性物合成生物学重点实验室、海南省再生医学技术与材料转化重点实验室、天津市生物合成与过程工程重点实验室、糖类智造及功能应用北京市重点实验室等科研平台,并参与共建国家合成生物技术创新中心及国家生物制造产业创新中心。凭借在技术创新和产业引领方面的突出表现,公司获得国家制造业单项冠军示范企业、国家知识产权优势企业、山东省科技进步一等奖、山东省省长质量奖、中国商业联合会特等奖等多项国家级、省级荣誉。
发行价格:
47.79
{"stockData":{"symbol":"688363","market":"SH","secType":"STK","nameCN":"华熙生物","latestPrice":34.6,"timestamp":1780556402000,"preClose":35.37,"halted":0,"volume":2976747,"delay":0,"changeRate":-0.0218,"floatShares":482000000,"shares":482000000,"eps":0.5291,"marketStatus":"已收盘","change":-0.77,"latestTime":"06-04 15:00:02","open":35.65,"high":35.68,"low":34.49,"amount":103000000,"amplitude":0.0336,"askPrice":34.7,"askSize":2,"bidPrice":34.6,"bidSize":33,"shortable":0,"etf":0,"ttmEps":0.5291,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780623000000},"marketStatusCode":5,"adr":0,"adjPreClose":35.37,"symbolType":"stock_kcb","openAndCloseTimeList":[[1780536600000,1780543800000],[1780549200000,1780556400000]],"highLimit":38.91,"lowLimit":31.83,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":481678242,"isCdr":false,"pbRate":2.34,"roa":"--","peRate":65.394065,"roe":"0.91%","epsLYR":0.61,"committee":0.194805,"marketValue":16666000000,"turnoverRate":0.0062,"status":1,"afterMarket":{"amount":0,"volume":0,"close":34.6,"buyVolume":0,"sellVolume":0,"time":1780558438866,"indexStatus":"已收盘 06-04 15:30:00","preClose":35.37},"floatMarketCap":16666000000},"requestUrl":"/m/hq/s/688363/","defaultTab":"news","newsList":[{"id":"2639048926","title":"每周股票复盘:华熙生物(688363)股东户数减少2.07%,控股东捐赠1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2639048926","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639048926?lang=zh_cn&edition=full","pubTime":"2026-05-31 02:41","pubTimestamp":1780166470,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,华熙生物报收于36.78元,较上周的39.0元下跌5.69%。本周,华熙生物5月25日盘中最高价报39.26元。公司公告汇总:控股股东华熙昕宇无偿捐赠公司1%股份,持股比例由60.11%降至59.11%。股本股东变化截至2026年5月8日,华熙生物股东户数为3.11万户,较3月31日减少658户,减幅2.07%。本次权益变动后,华熙昕宇及其一致行动人合计持股比例由60.11%降至59.11%,不触及要约收购,未导致公司控股股东及实际控制人变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688363","BK0239","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638653456","title":"破发股华熙生物跌2.49%创新低 2019年上市募23.69亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2638653456","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638653456?lang=zh_cn&edition=full","pubTime":"2026-05-28 16:17","pubTimestamp":1779956247,"startTime":"0","endTime":"0","summary":"中国经济网北京5月28日讯 华熙生物 今日收报35.59元,跌幅2.49%。该股今日盘中最低报35.22元,创上市以来股价新低。该股目前处于破发状态。 2019年11月6日,华熙生物在上交所科创板上市,发行价格为47.79元/股,募集资金总额为23.69亿元,扣除发行费用后,募集资金净额为22.49亿元。华熙生物的发行费用合计为11,964.01万元,其中保荐及承销费等为9,666.00万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260528/32261284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0229","688363","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638411075","title":"股市必读:华熙生物(688363)股东户数3.11万户,较上期减少2.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638411075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638411075?lang=zh_cn&edition=full","pubTime":"2026-05-27 01:29","pubTimestamp":1779816549,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘,华熙生物报收于36.84元,下跌2.49%,换手率0.7%,成交量3.37万手,成交额1.24亿元。股本股东变化股东户数变动近日华熙生物披露,截至2026年5月8日公司股东户数为3.11万户,较3月31日减少658.0户,减幅为2.07%。华熙生物关于召开2025年年度股东会的通知华熙生物科技股份有限公司将于2026年6月16日召开2025年年度股东会,会议采取现场投票与网络投票相结合方式,股权登记日为2026年6月8日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700001374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688363","BK0239","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638133555","title":"华熙生物(688363)披露2025年年度股东会会议资料,5月25日股价下跌3.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638133555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638133555?lang=zh_cn&edition=full","pubTime":"2026-05-25 22:19","pubTimestamp":1779718759,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘,华熙生物报收于37.78元,较前一交易日下跌3.13%,最新总市值为181.98亿元。近日,华熙生物科技股份有限公司披露《2025年年度股东会会议资料》。公告显示,公司将于2026年6月16日召开2025年年度股东会,审议2025年度董事会工作报告、董事高管薪酬管理制度修订、2026年度董事及高管薪酬方案、2025年度利润分配预案、续聘2026年度审计机构、授权董事会以简易程序向特定对象发行股票等议案。会议还听取了独立董事2025年度述职报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500034024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0239","688363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638535870","title":"破发股华熙生物跌3.13%创新低 2019年上市募23.69亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2638535870","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638535870?lang=zh_cn&edition=full","pubTime":"2026-05-25 15:43","pubTimestamp":1779694985,"startTime":"0","endTime":"0","summary":"中国经济网北京5月25日讯 华熙生物 今日盘中最低报37.74元,创上市以来股价新低。截至今日收盘,华熙生物报37.78元,跌幅3.13%。该股目前处于破发状态。 2019年11月6日,华熙生物在上交所科创板上市,发行价格为47.79元/股,募集资金总额为23.69亿元,扣除发行费用后,募集资金净额为22.49亿元。华熙生物的发行费用合计为11,964.01万元,其中保荐及承销费等为9,666.00万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260525/32251620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0229","688363","IPOS","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636061727","title":"每周股票复盘:华熙生物(688363)将参加投资者网上集体接待日活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2636061727","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636061727?lang=zh_cn&edition=full","pubTime":"2026-05-17 02:46","pubTimestamp":1778957172,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,华熙生物报收于39.94元,较上周的41.83元下跌4.52%。本周,华熙生物5月13日盘中最高价报42.1元。华熙生物当前最新总市值192.38亿元,在医疗美容板块市值排名2/3,在两市A股市值排名1136/5203。本周关注点公司公告汇总:华熙生物将参加2026年5月15日举行的山东辖区上市公司投资者网上集体接待日活动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0229","688363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633151940","title":"股市必读:华熙生物一季报 - 第一季度单季净利润同比下降36.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633151940","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633151940?lang=zh_cn&edition=full","pubTime":"2026-05-06 01:58","pubTimestamp":1778003889,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,华熙生物报收于41.35元,下跌4.61%,换手率1.08%,成交量5.19万手,成交额2.15亿元。来自业绩披露要点:华熙生物2026年一季度主营收入8.29亿元,同比下降23.06%;归母净利润6465.47万元,同比下降36.55%。股本股东变化股东户数变动近日华熙生物披露,截至2026年3月31日公司股东户数为3.18万户,较12月31日增加219.0户,增幅为0.69%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600000600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632418641","title":"每周股票复盘:华熙生物(688363)股东户数增0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632418641","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632418641?lang=zh_cn&edition=full","pubTime":"2026-05-02 02:37","pubTimestamp":1777660629,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,华熙生物报收于41.35元,较上周的42.75元下跌3.27%。本周,华熙生物4月27日盘中最高价报43.86元。股本股东变化股东户数变动截至2026年3月31日,公司股东户数为3.18万户,较2025年12月31日增加219.0户,增幅0.69%。公司公告汇总华熙生物关于提请股东会授权董事会以简易程序向特定对象发行股票的公告华熙生物于2026年4月29日召开第三届董事会第七次会议,审议通过《关于提请股东会授权董事会以简易程序向特定对象发行股票的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688363","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660739","title":"华熙生物(688363)2026年一季报简析:净利润同比下降36.55%,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660739","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632660739?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:49","pubTimestamp":1777589366,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期华熙生物发布2026年一季报。截至本报告期末,公司营业总收入8.29亿元,同比下降23.06%,归母净利润6465.47万元,同比下降36.55%。本报告期华熙生物公司应收账款体量较大,当期应收账款占最新年报归母净利润比达204.75%。去年的净利率为6.93%,算上全部成本后,公司产品或服务的附加值一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100007300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631655194","title":"华熙生物(688363)披露提请股东会授权董事会以简易程序向特定对象发行股票的公告,4月30日股价下跌4.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631655194","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631655194?lang=zh_cn&edition=full","pubTime":"2026-04-30 22:05","pubTimestamp":1777557925,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,华熙生物报收于41.35元,较前一交易日下跌4.61%,最新总市值为199.17亿元。华熙生物科技股份有限公司于2026年4月29日召开第三届董事会第七次会议,审议通过《关于提请股东会授权董事会以简易程序向特定对象发行股票的议案》。本次发行股票限售期为六个月或十八个月。该事项尚需提交股东会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000068286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688363","BK0239","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631387516","title":"华熙生物最新公告:第一季度净利润同比下降36.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631387516","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631387516?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:49","pubTimestamp":1777463385,"startTime":"0","endTime":"0","summary":"华熙生物(688363.SH)公告称,2026年第一季度实现营业收入8.29亿元,同比下降23.06%;归属于上市公司股东的净利润为0.65亿元,同比下降36.55%。业绩变动主要系皮肤科学创新转化业务收入同比下降所致。注:公司Q1净利润0.65亿,2025年Q4净利润0.4亿,据此计算,Q1净利润环比增长62%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900060792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630804976","title":"每周股票复盘:华熙生物(688363)2025年净利增67.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630804976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630804976?lang=zh_cn&edition=full","pubTime":"2026-04-26 03:50","pubTimestamp":1777146622,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,华熙生物报收于42.75元,较上周的43.2元下跌1.04%。本周关注点来自业绩披露要点:华熙生物2025年归母净利润2.92亿元,同比上升67.59%。股本股东变化截至2026年3月31日,华熙生物股东户数为3.18万户,较2025年12月31日增加219.0户,增幅0.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0239","688363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629850883","title":"股市必读:华熙生物年报 - 第四季度单季净利润同比增长121.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629850883","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629850883?lang=zh_cn&edition=full","pubTime":"2026-04-24 03:43","pubTimestamp":1776973400,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动近日华熙生物披露,截至2026年3月31日公司股东户数为3.18万户,较12月31日增加219.0户,增幅为0.69%。公司公告汇总华熙生物2025年年度报告摘要华熙生物2025年年度报告摘要显示,公司实现营业收入41.99亿元,同比下降21.82%;归属于上市公司股东的净利润为2.92亿元,同比增加67.59%;归属于上市公司股东的扣除非经常性损益后的净利润为1.86亿元,同比增加73.76%;经营活动产生的现金流量净额为6.27亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400009687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629045540","title":"华熙生物最新公告:2025年净利润2.92亿元同比增长67.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629045540","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629045540?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:40","pubTimestamp":1776858058,"startTime":"0","endTime":"0","summary":"华熙生物(688363.SH)发布2025年年度报告,实现营业收入41.99亿元,同比下降21.82%;归属于上市公司股东的净利润为2.92亿元,同比增长67.59%。公司拟向全体股东每10股派发现金红利1.90元(含税)。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200048238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629090949","title":"国货美妆品牌抢占线下折扣店","url":"https://stock-news.laohu8.com/highlight/detail?id=2629090949","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629090949?lang=zh_cn&edition=full","pubTime":"2026-04-22 15:24","pubTimestamp":1776842640,"startTime":"0","endTime":"0","summary":"国货美妆品牌抢占线下折扣店","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604223713962495.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604223713962495.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["600315","LU1146622755.USD","BK0196","BK0028","SG9999004311.SGD","LU2460026573.USD","BK0070","LU1997245094.SGD","IE0005HP3H50.USD","603605","BK0012","301371","BK0273","LU1820825898.SGD","02367","LU0593848301.USD","LU0274383008.USD","BK0188","BK0239","300957","688363","LU2488822045.USD","BK1207","600223","LU1997245177.USD","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621777168","title":"破发股华熙生物跌5.81%创新低 2019年上市募23.69亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2621777168","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621777168?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:29","pubTimestamp":1774258151,"startTime":"0","endTime":"0","summary":"中国经济网北京3月23日讯 华熙生物 今日收报40.50元,跌幅5.81%。华熙生物今日盘中股价最低至40.36元,创历史新低。该股目前处于破发状态。 2019年11月6日,华熙生物在上交所科创板上市,发行价格为47.79元/股,募集资金总额为23.69亿元,扣除发行费用后,募集资金净额为22.49亿元。华熙生物的发行费用合计为 11,964.01 万元,其中保荐及承销费等为9,666.00万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260323/32090564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","688363","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619344024","title":"玻尿酸王座崩塌:华熙生物从1400亿到217亿的生死突围","url":"https://stock-news.laohu8.com/highlight/detail?id=2619344024","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619344024?lang=zh_cn&edition=full","pubTime":"2026-03-16 14:40","pubTimestamp":1773643239,"startTime":"0","endTime":"0","summary":"文|《思维深潜研究组》2026 年 2 月末,华熙生物 2025 年业绩快报落地:全年营收 42.17 亿元,同比下滑 21.49%;归母净利润 2.91 亿元,同比大增 67.03%。流量驱动、多品牌分散、渠道价格混乱,叠加行业退潮,华熙从神坛跌落,当前市值约 217 亿元。玻尿酸基本盘之外,胶原蛋白、聚乳酸、合成生物学、再生材料决定未来市值。华熙生物的起落、三强的鏖战、C 端的突围、全球化的起步,共同构成中国制造向中国品牌升级的缩影。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1773563588661892485","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["688363","BK0239","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617663216","title":"华熙生物公布国际专利申请:“油性组合物及其用途”","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663216","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663216?lang=zh_cn&edition=full","pubTime":"2026-03-08 05:16","pubTimestamp":1772918181,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示华熙生物(688363)公布了一项国际专利申请,专利名为“油性组合物及其用途”,专利申请号为PCT/CN2025/116285,国际公布日为2026年3月5日。专利详情如下:图片来源:世界知识产权组织(WIPO)今年以来华熙生物已公布的国际专利申请2个,较去年同期增加了100%。结合公司2025年中报财务数据,2025上半年公司在研发方面投入了2.31亿元,同比增15.25%。数据来源:企查查以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688363","BK0239","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616333262","title":"华熙生物2025年营收42亿:同比降21% 净利2.9亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2616333262","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616333262?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:55","pubTimestamp":1772456102,"startTime":"0","endTime":"0","summary":"华熙生物(证券代码:688363)日前发布2025年业绩快报,业绩快报显示,华熙生物2025年营收42.17亿,较上年同期的53.71亿元降21.49%。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260302/6390808169942304828177013.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260302/6390808169942304828177013.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32767/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["688363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616488843","title":"每周股票复盘:华熙生物(688363)净利增67.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616488843","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616488843?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:13","pubTimestamp":1772302390,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,华熙生物报收于47.36元,较上周的47.25元上涨0.23%。本周,华熙生物2月25日盘中最高价报48.82元。华熙生物当前最新总市值228.12亿元,在医疗美容板块市值排名2/3,在两市A股市值排名977/5189。本周关注点业绩披露要点:华熙生物2025年归属净利润同比增长67.03%。公司公告汇总华熙生物发布2025年度业绩快报,营业总收入为42.17亿元,同比下降21.49%;归属于母公司所有者的净利润为2.91亿元,同比增长67.03%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688363","BK0229","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780600222539,"stockEarnings":[{"period":"1week","weight":-0.0278},{"period":"1month","weight":-0.1632},{"period":"3month","weight":-0.2337},{"period":"6month","weight":-0.2452},{"period":"1year","weight":-0.3774},{"period":"ytd","weight":-0.2079}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0132},{"period":"3month","weight":-0.0161},{"period":"6month","weight":0.0397},{"period":"1year","weight":0.2019},{"period":"ytd","weight":0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华熙生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"31133人(较上一季度减少0.41%)","perCapita":"15471股","listingDate":"2019-11-06","address":"山东省济南市历下区高新技术开发区天辰大街678号","registeredCapital":"48167万元","survey":" 华熙生物科技股份有限公司的主营业务是研发、生产和销售透明质酸等生物活性物质原料产品及生物医用材料终端产品。公司的主要产品是原料产品、医疗终端产品、皮肤科学创新转化业务。公司坚持科技创新驱动发展,科技创新能力多次获得国家及各级政府认可。公司先后被认定为国家企业技术中心、国家药监局化妆品原料质量控制重点实验室(联合申报)、山东省生物活性物合成生物学重点实验室、海南省再生医学技术与材料转化重点实验室、天津市生物合成与过程工程重点实验室、糖类智造及功能应用北京市重点实验室等科研平台,并参与共建国家合成生物技术创新中心及国家生物制造产业创新中心。凭借在技术创新和产业引领方面的突出表现,公司获得国家制造业单项冠军示范企业、国家知识产权优势企业、山东省科技进步一等奖、山东省省长质量奖、中国商业联合会特等奖等多项国家级、省级荣誉。","listedPrice":47.79},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华熙生物(688363)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华熙生物(688363)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华熙生物,688363,华熙生物股票,华熙生物股票老虎,华熙生物股票老虎国际,华熙生物行情,华熙生物股票行情,华熙生物股价,华熙生物股市,华熙生物股票价格,华熙生物股票交易,华熙生物股票购买,华熙生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华熙生物(688363)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华熙生物(688363)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}